SLC18A2 and Parkinson disease: The function of striatal dopamine terminals in PD can be examined in vivo by examining dopamine transporter (DAT) and monoamine vesicle transporter (VMAT2) availability with either PET or SPECT or dopamine storage capacity with 18F-dopa PET [28].